𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment

✍ Scribed by Chun-Nan Yeh; Tsung-Wen Chen; Jeng-Hwei Tseng; Yu-Yin Liu; Shang-Yu Wang; Chun-Yi Tsai; Kun-Chun Chiang; Tsann-Long Hwang; Yi-Yin Jan; Miin-Fu Chen


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
554 KB
Volume
102
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Resection of residual disease in patient
✍ Sebastian Bauer; JΓΆrg Thomas Hartmann; Maike de Wit; Hauke Lang; Florian Grabell πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 723 KB

## Abstract Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. Long‐term survival of patients with metastatic disease has only been observed in patients with completely resected disease. Recently, the tyrosine kinase inhibitor imatinib has b